| Name | 6-chloro-2-methyl-5-nitro-N-pentan-3-ylpyrimidin-4-amine |
|---|---|
| Synonyms |
2-methyl-4-chloro-5-nitro-6-(3-pentylamino)-pyrimidine
(6-chloro-2-methyl-5-nitro-pyrimidin-4-yl)-(1-ethyl-propyl)-amine 4-Pyrimidinamine,6-chloro-N-(1-ethylpropyl)-2-methyl-5-nitro |
| Molecular Formula | C10H15ClN4O2 |
|---|---|
| Molecular Weight | 258.70500 |
| Exact Mass | 258.08800 |
| PSA | 83.63000 |
| LogP | 3.54330 |
|
~%
53039-38-6 |
| Literature: Neurocrine Biosciences, Inc. Patent: US6348466 B1, 2002 ; Location in patent: Page column 15 ; US 6348466 B1 |
|
~34%
53039-38-6 |
| Literature: Pfizer Inc. Patent: US6956047 B1, 2005 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |